Skip to main content

Paula Tagliani

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Paula Tagliani

Institutions of which they are part

Predoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Stefania Spiliopoulou,

Stefania Spiliopoulou,

Research technician
Physical Medicine and Rehabilitation
Read more
Eddie Pradas Gracia

Eddie Pradas Gracia

Research technician
Neurodegenerative Diseases
Read more
Cristina Raventós Aymar

Cristina Raventós Aymar

Predoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Bouchra Aboudou

Bouchra Aboudou

Administration and Management
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.